China’s surgical robot gains EU market access, AI model tops benchmark

Key facts

• Shanghai MicroPort MedBot's Toumai Remote surgical robot received EU market approval.
• The Toumai Remote is a teleoperated surgical robot.
• The robot enables remote laparoscopic surgeries.
• The system has been used in the UK for a long-distance procedure.
• The approval marks an advancement for Chinese medical AI.

Shanghai MicroPort MedBot's Toumai Remote surgical robot has secured approval for the European Union market, representing a major step forward for China's artificial intelligence in medicine. The teleoperated system is designed to enable surgeons to perform laparoscopic surgeries remotely. This advanced technology has already seen practical application, having been utilized in the United Kingdom for a long-distance surgical procedure. The EU market approval signifies a growing international acceptance and potential for Chinese medical AI technologies to compete on a global scale. This development highlights the increasing sophistication and reach of China's contributions to the field of medical robotics and AI-driven healthcare solutions.